Tiziana Life Sciences PLC Director/PDMR Shareholding (7450Z)
January 14 2020 - 6:00AM
UK Regulatory
TIDMTILS
RNS Number : 7450Z
Tiziana Life Sciences PLC
14 January 2020
Tiziana Life Sciences plc
PDMR Dealing
New York/London, 14 January 2020 - Tiziana Life Sciences plc
(Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the
discovery and development of innovative therapeutics for
inflammation and oncology indications, announces that on the 13
January 2020 it was informed that on that date, Panetta Partners
Limited, an entity closely associated with Gabriele Cerrone,
Executive Chairman, bought 28,500 Ordinary Shares at a price of 43
pence per Ordinary Share, as set out below.
The information set out below is provided in accordance with the
requirements of Regulation 19(3) of the EU Market Abuse Regulation
No 596/2014:
1. Details of PDMR / person closely associated
a) Name Gabriele Cerrone/Panetta Partners
Limited
2. Reason for the notification: On market acquisition
a) Position / status Executive Chairman
b) Initial notification /amendment Initial notification
3. Details of the issuer
a) Name Tiziana Life Sciences plc
b) LEI 213800CED47HI8PIOB36
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary Shares
instrument
b) Identification code of the GB00BKWNZY55
Financial Instrument
c) Nature of the transaction On market acquisition of ordinary
shares
d) Price(s) and volume(s) Price: 43 pence; Volume: 28,500
e) Aggregated information
- Aggregated volume N/A
- Price N/A
f) Date of the transaction 13 January 2020
g) Place of the transaction AIM
As a result of this transaction Mr Cerrone's interests in the
underlying ordinary shares of the Company increases from 64,318,425
(47.066%) to 64,346,925 (47.087%). Mr Cerrone's interests in the
ordinary shares of the Company are based on a holding of 63,680,404
ordinary shares held by Planwise Limited and voting rights in
respect of 666,521 ordinary shares held by Panetta Partners Limited
(as shares and via ADSs). Mr Cerrone is considered beneficially
interested in the holdings of Panetta Partners Limited and Planwise
Limited.
For more information go to
http://www.tizianalifesciences.com
Contacts:
Tiziana Life Sciences plc
Gabriele Cerrone, Chairman and founder +44 (0)20 7495 2379
Cairn Financial Advisers LLP (Nominated
adviser)
Liam Murray / Jo Turner +44 (0)20 7213 0883
Shore Capital (Broker)
Antonio Bossi / Fiona Conroy +44 (0)20 7408 4050
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBGGDBUDBDGGS
(END) Dow Jones Newswires
January 14, 2020 06:00 ET (11:00 GMT)
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From Apr 2024 to May 2024
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From May 2023 to May 2024